EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cytokine Profiles in Peripheral Blood Mononuclear Cells and Neutrophils following SARS-CoV-2 Vaccination: A Study from Kuwait

Mais A Abdulwahab, Sahar Essa, Raj Raghupathy

Medical Principles and Practice · 29.06.2026 · 1-16

DOI: 10.1159/000553305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Principles and Practice, online erschienen am 29.06.2026. Verfasst von Mais A Abdulwahab und 2 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study characterized cytokine profiles in peripheral blood mononuclear cells (PBMC) and neutrophils following SARS-CoV-2 vaccination with Pfizer-BioNTech (mRNA-based) and AstraZeneca (adenoviral vector-based) vaccines in Kuwait. Subjects and Methods: The study included 200 adult participants: 100 unvaccinated healthy controls; 18 recipients of two Pfizer-BioNTech doses; 32 recipients of two AstraZeneca doses; and 50 recipients of a third Pfizer-BioNTech dose. Blood samples were collected at 0–2 months and 3–6 months after vaccination, and cytokines were measured in mitogen-stimulated PBMC and neutrophil culture supernatants.

Results

Both vaccine platforms induced measurable cytokine responses, but the cytokine patterns differed according to vaccine type, cell population, and time after vaccination. Pfizer-BioNTech vaccination was associated with an early Th2-skewed profile in PBMC, while AstraZeneca vaccination showed broader activation of Th1/Th2/Th17-associated cytokines. IL-6 and IL-10 decreased over time in several comparisons; however, these findings should be interpreted with caution because cytokine concentrations are dynamic and may vary with sampling time, cell type, and stimulation conditions. Overall, vaccine-induced cytokine profiles waned by 3–6 months after primary vaccination, whereas the third Pfizer-BioNTech dose enhanced several PBMC cytokine responses.

Conclusions

These findings support the immunomodulatory effects of SARS-CoV-2 vaccines and highlight the value of booster vaccination for sustaining cellular immune responsiveness.

Schlagwörter

Stichwörter der Autor:innen

AstraZenecaCytokinesNeutrophilsPeripheral blood mononuclear cellsPfizerSARS-CoV-2

Autor:innen und Institutionen

  • Microbiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait.
  • Microbiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait, sahar.essa@ku.edu.kw.

Zitieren

APA

Abdulwahab, M. A., Essa, S., & Raghupathy, R. (2026). Cytokine Profiles in Peripheral Blood Mononuclear Cells and Neutrophils following SARS-CoV-2 Vaccination: A Study from Kuwait. Medical Principles and Practice, 1-16. https://doi.org/10.1159/000553305

Vancouver

Abdulwahab MA, Essa S, Raghupathy R. Cytokine Profiles in Peripheral Blood Mononuclear Cells and Neutrophils following SARS-CoV-2 Vaccination: A Study from Kuwait. Medical Principles and Practice. 2026:1-16. doi:10.1159/000553305

BibTeX
@article{Abdulwahab2026,
  author = {Abdulwahab, Mais A and Essa, Sahar and Raghupathy, Raj},
  title = {Cytokine Profiles in Peripheral Blood Mononuclear Cells and Neutrophils following SARS-CoV-2 Vaccination: A Study from Kuwait},
  journal = {Medical Principles and Practice},
  year = {2026},
  pages = {1--16},
  doi = {10.1159/000553305}
}
Kostenlos starten →